Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Defibrillators, Implantable | 14 | 2016 | 142 | 2.020 |
Why?
|
| Cardiac Pacing, Artificial | 8 | 2012 | 98 | 1.490 |
Why?
|
| Sarcoidosis | 6 | 2016 | 72 | 1.300 |
Why?
|
| Pacemaker, Artificial | 7 | 2013 | 94 | 1.180 |
Why?
|
| Electrodes, Implanted | 4 | 2013 | 177 | 0.990 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2014 | 197 | 0.970 |
Why?
|
| Heart Failure | 11 | 2018 | 1180 | 0.950 |
Why?
|
| Cardiomyopathies | 4 | 2016 | 264 | 0.890 |
Why?
|
| Long QT Syndrome | 2 | 2016 | 36 | 0.640 |
Why?
|
| Cardiac Resynchronization Therapy | 6 | 2018 | 68 | 0.620 |
Why?
|
| Ventricular Dysfunction, Left | 6 | 2015 | 329 | 0.620 |
Why?
|
| Equipment Failure Analysis | 5 | 2013 | 89 | 0.590 |
Why?
|
| Ventricular Fibrillation | 2 | 2013 | 68 | 0.530 |
Why?
|
| Gadolinium | 1 | 2014 | 103 | 0.450 |
Why?
|
| Kidney Function Tests | 1 | 2013 | 113 | 0.440 |
Why?
|
| Coronary Angiography | 1 | 2013 | 242 | 0.410 |
Why?
|
| Echocardiography | 5 | 2016 | 937 | 0.390 |
Why?
|
| Electrocardiography | 8 | 2016 | 493 | 0.380 |
Why?
|
| Atrial Fibrillation | 7 | 2015 | 350 | 0.370 |
Why?
|
| Acute Kidney Injury | 1 | 2013 | 311 | 0.340 |
Why?
|
| Catheter Ablation | 4 | 2016 | 252 | 0.330 |
Why?
|
| Ultrasonography, Doppler | 1 | 2009 | 85 | 0.330 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 362 | 0.320 |
Why?
|
| Safety | 1 | 2009 | 149 | 0.320 |
Why?
|
| Cardiac Electrophysiology | 1 | 2008 | 7 | 0.320 |
Why?
|
| Tachycardia, Ventricular | 3 | 2016 | 124 | 0.320 |
Why?
|
| Electric Countershock | 3 | 2016 | 53 | 0.300 |
Why?
|
| Ventricular Function, Left | 4 | 2016 | 603 | 0.300 |
Why?
|
| Bundle-Branch Block | 1 | 2007 | 54 | 0.280 |
Why?
|
| Quality of Life | 4 | 2016 | 1662 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3443 | 0.250 |
Why?
|
| Humans | 39 | 2018 | 89063 | 0.250 |
Why?
|
| Middle Aged | 18 | 2016 | 25863 | 0.240 |
Why?
|
| Heart Ventricles | 1 | 2009 | 779 | 0.230 |
Why?
|
| Male | 26 | 2018 | 42251 | 0.230 |
Why?
|
| Female | 23 | 2018 | 46011 | 0.230 |
Why?
|
| Prevalence | 4 | 2016 | 1240 | 0.200 |
Why?
|
| Heart Diseases | 2 | 2016 | 298 | 0.200 |
Why?
|
| Stroke Volume | 6 | 2016 | 462 | 0.190 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 2 | 2016 | 19 | 0.170 |
Why?
|
| Risk Assessment | 3 | 2016 | 2290 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2018 | 20 | 0.160 |
Why?
|
| Prognosis | 6 | 2018 | 3773 | 0.160 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 48 | 0.160 |
Why?
|
| Equipment Design | 5 | 2016 | 415 | 0.160 |
Why?
|
| Equipment Failure | 4 | 2012 | 121 | 0.160 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 192 | 0.150 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2010 | 42 | 0.140 |
Why?
|
| Treatment Outcome | 11 | 2016 | 8203 | 0.140 |
Why?
|
| Heart Failure, Systolic | 1 | 2016 | 5 | 0.140 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2014 | 52 | 0.140 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2016 | 56 | 0.130 |
Why?
|
| Adult | 10 | 2016 | 26507 | 0.130 |
Why?
|
| Heart Rate | 2 | 2016 | 493 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2016 | 235 | 0.120 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2014 | 27 | 0.120 |
Why?
|
| Differential Threshold | 1 | 2013 | 12 | 0.120 |
Why?
|
| Hospitalization | 2 | 2016 | 876 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 685 | 0.110 |
Why?
|
| Causality | 1 | 2013 | 80 | 0.110 |
Why?
|
| Sex Factors | 1 | 2016 | 1063 | 0.110 |
Why?
|
| Aged | 10 | 2018 | 19077 | 0.110 |
Why?
|
| Anesthesiology | 1 | 2015 | 161 | 0.110 |
Why?
|
| Cardiology | 1 | 2014 | 115 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2016 | 567 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2016 | 9003 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 225 | 0.100 |
Why?
|
| Consensus | 1 | 2014 | 356 | 0.100 |
Why?
|
| Oxygen Consumption | 2 | 2015 | 243 | 0.100 |
Why?
|
| Systole | 1 | 2011 | 115 | 0.100 |
Why?
|
| Acetanilides | 1 | 2010 | 6 | 0.090 |
Why?
|
| Syndactyly | 1 | 2010 | 12 | 0.090 |
Why?
|
| Prosthesis Design | 2 | 2013 | 296 | 0.090 |
Why?
|
| Brugada Syndrome | 1 | 2010 | 14 | 0.090 |
Why?
|
| Ventricular Septum | 1 | 2010 | 14 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2014 | 426 | 0.090 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 321 | 0.090 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2010 | 32 | 0.090 |
Why?
|
| Ventricular Remodeling | 2 | 2009 | 105 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 475 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2010 | 65 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2014 | 570 | 0.090 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2011 | 161 | 0.090 |
Why?
|
| Punctures | 1 | 2009 | 29 | 0.090 |
Why?
|
| Primary Prevention | 1 | 2010 | 81 | 0.090 |
Why?
|
| Needles | 1 | 2009 | 36 | 0.090 |
Why?
|
| Heart Septum | 1 | 2009 | 47 | 0.090 |
Why?
|
| Comorbidity | 1 | 2013 | 948 | 0.090 |
Why?
|
| Incidence | 1 | 2013 | 1592 | 0.080 |
Why?
|
| Silicone Elastomers | 1 | 2008 | 7 | 0.080 |
Why?
|
| Polyurethanes | 1 | 2008 | 10 | 0.080 |
Why?
|
| Electrocoagulation | 1 | 2008 | 23 | 0.080 |
Why?
|
| Chicago | 1 | 2013 | 1423 | 0.080 |
Why?
|
| Piperazines | 1 | 2010 | 283 | 0.080 |
Why?
|
| Myocardium | 1 | 2011 | 571 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1591 | 0.080 |
Why?
|
| Hot Temperature | 1 | 2008 | 208 | 0.080 |
Why?
|
| Medicare | 1 | 2011 | 423 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2007 | 287 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2007 | 101 | 0.070 |
Why?
|
| Heart Conduction System | 1 | 2007 | 112 | 0.070 |
Why?
|
| Risk Factors | 3 | 2013 | 5466 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 389 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2007 | 403 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 186 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2013 | 756 | 0.070 |
Why?
|
| Hyperlipidemias | 1 | 2006 | 92 | 0.070 |
Why?
|
| Body Height | 1 | 2006 | 100 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 6777 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2006 | 99 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2006 | 98 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2007 | 859 | 0.060 |
Why?
|
| Stroke | 1 | 2014 | 982 | 0.060 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2009 | 516 | 0.060 |
Why?
|
| Surgical Wound Infection | 1 | 2006 | 201 | 0.060 |
Why?
|
| Research Design | 1 | 2007 | 597 | 0.060 |
Why?
|
| Heart Block | 1 | 2003 | 31 | 0.050 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2012 | 25 | 0.050 |
Why?
|
| Decision Support Techniques | 2 | 2016 | 167 | 0.050 |
Why?
|
| Exercise Test | 2 | 2015 | 165 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 833 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 461 | 0.050 |
Why?
|
| Atrial Flutter | 1 | 2001 | 35 | 0.050 |
Why?
|
| Time Factors | 3 | 2016 | 5320 | 0.050 |
Why?
|
| Monitoring, Physiologic | 2 | 2012 | 266 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2001 | 260 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1715 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2001 | 234 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 301 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2752 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2016 | 36 | 0.030 |
Why?
|
| Device Approval | 1 | 2016 | 13 | 0.030 |
Why?
|
| Models, Economic | 1 | 2016 | 62 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2016 | 61 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2016 | 142 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2016 | 107 | 0.030 |
Why?
|
| Laboratories | 1 | 2015 | 44 | 0.030 |
Why?
|
| Operating Rooms | 1 | 2015 | 129 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 251 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 1140 | 0.030 |
Why?
|
| Sick Sinus Syndrome | 1 | 2012 | 9 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2012 | 2863 | 0.030 |
Why?
|
| Contraindications | 1 | 2012 | 70 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 682 | 0.030 |
Why?
|
| Death, Sudden | 1 | 2012 | 40 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1755 | 0.030 |
Why?
|
| Biopsy | 1 | 2016 | 1182 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2014 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1710 | 0.020 |
Why?
|
| Registries | 2 | 2006 | 778 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 1488 | 0.020 |
Why?
|
| Ranolazine | 1 | 2010 | 4 | 0.020 |
Why?
|
| Verapamil | 1 | 2010 | 34 | 0.020 |
Why?
|
| Contrast Media | 1 | 2016 | 1090 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2011 | 153 | 0.020 |
Why?
|
| Ventricular Dysfunction | 1 | 2010 | 28 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2014 | 447 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2010 | 150 | 0.020 |
Why?
|
| Device Removal | 1 | 2011 | 167 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2009 | 156 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 3657 | 0.020 |
Why?
|
| Materials Testing | 1 | 2008 | 93 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 131 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 783 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2009 | 252 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2009 | 292 | 0.020 |
Why?
|
| Observer Variation | 1 | 2009 | 610 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 4273 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2009 | 865 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 948 | 0.020 |
Why?
|
| Body Surface Area | 1 | 2006 | 36 | 0.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 46 | 0.020 |
Why?
|
| United States | 2 | 2011 | 6955 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 91 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2006 | 105 | 0.020 |
Why?
|
| Creatinine | 1 | 2006 | 293 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 901 | 0.010 |
Why?
|
| Heart Atria | 1 | 2006 | 281 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1837 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 988 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2006 | 458 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 376 | 0.010 |
Why?
|
| Logistic Models | 1 | 2006 | 1212 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 1855 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 353 | 0.010 |
Why?
|
| Ethanol | 1 | 2003 | 250 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 6288 | 0.010 |
Why?
|
| Adolescent | 1 | 2009 | 9237 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2001 | 2275 | 0.010 |
Why?
|